Lunel, Thibault
Mohkam, Kayvan http://orcid.org/0000-0002-9695-0902
Merle, Philippe
Bonnet, Aurélie
Gazon, Mathieu
Dumont, Paul‐Noël
Ducerf, Christian
Mabrut, Jean‐Yves http://orcid.org/0000-0002-5701-3588
Lesurtel, Mickaël http://orcid.org/0000-0003-2397-4599
Article History
Accepted: 21 June 2021
First Online: 16 July 2021
Declarations
:
: Philippe Merle has served on the advisory board of Roche, AstraZeneca, Ipsen, MSD, Eisai, Bayer, and Lilly. He has also served as a consultant for Ipsen, Eisai, and Onxeo and received grants from Ipsen and Onxeo. The other authors declare that they have no conflict of interests.